Altimmune (ALT) Receivables - Other (2010 - 2026)
Altimmune (ALT) posted quarterly Receivables - Other of $1.4 million for Q1 2026, up 250.0% year-over-year from $400000.0 in Q1 2025, and up 27.27% quarter-over-quarter from $1.1 million in Q4 2025.
Altimmune (ALT) Receivables - Other (2010 - 2026) Analysis & Trends
Altimmune (ALT) has reported Receivables - Other for 12 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other rose 250.0% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 250.0% YoY), while the FY2025 annual figure was $1.1 million, up 175.0% from the prior year.
- Receivables - Other advanced to $1.4 million in Q1 2026 per ALT's latest filing, from $1.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.4 million in Q1 2026 and bottomed at $100000.0 in Q4 2023.
- Historically, Receivables - Other has averaged $544444.4 across 4 years, with a median of $400000.0 in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Other soared 300.0% — and 2025, when it jumped 100.0%.
- Altimmune's Receivables - Other stood at $100000.0 in 2023, then jumped by 300.0% to $400000.0 in 2024, then soared by 175.0% to $1.1 million in 2025, then climbed by 27.27% to $1.4 million in 2026.
- Business Quant data shows ALT's Receivables - Other at $1.4 million in Q1 2026, $1.1 million in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.30 Mn |
| Jun 30, 2026 | 3.30 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Dec 31, 2024 | 400,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |